Brokerages predict that Danaher Co. (NYSE:DHR) will post $0.93 earnings per share for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Danaher’s earnings. The highest EPS estimate is $0.96 and the lowest is $0.91. Danaher reported earnings of $0.85 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 9.4%. The business is expected to report its next earnings results before the market opens on Thursday, April 19th.
According to Zacks, analysts expect that Danaher will report full-year earnings of $4.38 per share for the current financial year, with EPS estimates ranging from $4.30 to $4.51. For the next fiscal year, analysts anticipate that the business will report earnings of $4.77 per share, with EPS estimates ranging from $4.64 to $4.98. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Danaher.
Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The firm had revenue of $5.09 billion for the quarter, compared to analysts’ expectations of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. The firm’s revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.05 earnings per share.
Several analysts recently weighed in on DHR shares. Stifel Nicolaus raised their target price on shares of Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Cowen reaffirmed a “buy” rating and issued a $110.00 target price on shares of Danaher in a report on Tuesday, January 30th. UBS began coverage on shares of Danaher in a report on Monday, January 22nd. They set a “buy” rating and a $99.97 price objective on the stock. Robert W. Baird reissued a “buy” rating on shares of Danaher in a report on Friday, January 12th. Finally, Citigroup raised their price objective on shares of Danaher to $107.00 and gave the stock a “buy” rating in a report on Friday, December 15th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $102.18.
In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the business’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the sale, the senior vice president now directly owns 82,008 shares in the company, valued at approximately $8,388,598.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Rainer Blair sold 51,080 shares of the business’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $97.26, for a total transaction of $4,968,040.80. Following the sale, the insider now owns 50,477 shares in the company, valued at $4,909,393.02. The disclosure for this sale can be found here. Over the last quarter, insiders sold 313,260 shares of company stock worth $31,657,786. 11.90% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. raised its stake in shares of Danaher by 4.6% during the 4th quarter. BlackRock Inc. now owns 40,984,366 shares of the conglomerate’s stock worth $3,804,169,000 after buying an additional 1,789,474 shares during the last quarter. American Century Companies Inc. raised its stake in shares of Danaher by 81.6% during the 4th quarter. American Century Companies Inc. now owns 2,832,466 shares of the conglomerate’s stock worth $262,909,000 after buying an additional 1,272,440 shares during the last quarter. Renaissance Technologies LLC raised its stake in shares of Danaher by 1,094.1% during the 4th quarter. Renaissance Technologies LLC now owns 1,149,900 shares of the conglomerate’s stock worth $106,734,000 after buying an additional 1,053,600 shares during the last quarter. Sterling Capital Management LLC raised its stake in shares of Danaher by 17,148.4% during the 3rd quarter. Sterling Capital Management LLC now owns 666,650 shares of the conglomerate’s stock worth $57,185,000 after buying an additional 662,785 shares during the last quarter. Finally, Amundi Pioneer Asset Management Inc. acquired a new position in shares of Danaher during the 4th quarter worth $59,642,000. Institutional investors own 77.67% of the company’s stock.
Shares of NYSE:DHR opened at $99.00 on Friday. The company has a market capitalization of $68,654.78, a P/E ratio of 24.57, a PEG ratio of 1.89 and a beta of 1.03. Danaher has a fifty-two week low of $78.97 and a fifty-two week high of $104.82. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.05 and a current ratio of 1.43.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 0.65%. This is a positive change from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend is Wednesday, March 28th. Danaher’s dividend payout ratio (DPR) is 15.88%.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/13/zacks-analysts-expect-danaher-co-dhr-to-announce-0-93-earnings-per-share.html.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Get a free copy of the Zacks research report on Danaher (DHR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.